Does DALTEPARIN Cause Malignant neoplasm progression? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Malignant neoplasm progression have been filed in association with DALTEPARIN (Fragmin). This represents 0.8% of all adverse event reports for DALTEPARIN.
27
Reports of Malignant neoplasm progression with DALTEPARIN
0.8%
of all DALTEPARIN reports
7
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From DALTEPARIN?
Of the 27 reports, 7 (25.9%) resulted in death, 8 (29.6%) required hospitalization, and 3 (11.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DALTEPARIN. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does DALTEPARIN Cause?
Off label use (352)
Nausea (316)
Abdominal pain (283)
Multiple organ dysfunction syndrome (282)
Vomiting (282)
Hyponatraemia (257)
General physical health deterioration (253)
Sepsis (252)
Constipation (247)
Abdominal distension (245)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which DALTEPARIN Alternatives Have Lower Malignant neoplasm progression Risk?
DALTEPARIN vs DAMOCTOCOG ALFA PEGOL
DALTEPARIN vs DANAPAROID
DALTEPARIN vs DANAZOL
DALTEPARIN vs DANICOPAN
DALTEPARIN vs DANTROLENE